Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 204 member C, pseudogene (FAM204CP) is a processed pseudogene in the human genome[2][4][5]. As a pseudogene, it is classified as a non-protein-coding genomic element, which means it does not encode a functional protein product[6]. Pseudogenes are sequences that closely resemble known genes but have lost their ability to code for proteins due to mutations or evolutionary processes. Although some pseudogenes may be transcribed and can act as regulators of gene expression via RNA-based mechanisms, FAM204CP is not recognized as a functional gene, receptor, enzyme, or therapeutic target, and there is currently no evidence for its direct involvement in any biological pathway, disease state, or drug interaction[4][2][6]. If new data identifies any specific functional RNA product or regulatory activity for FAM204CP, that would need to be annotated, but as of current data, it is not considered biologically active nor therapeutically relevant[4][2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 204 member C, pseudogene (FAM204CP).